CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology IndustryFrost & SullivanJuly 29, 2009 54 Pages - SKU: MC2402132 |
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
5/15/2012 | published by: GBI Research
Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity
Summary
GBI Research, the leading
|
more...
|
$3,500.00
|
|
Ferring Pharmaceuticals, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Ferring Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Ferring Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Ferring Pharmaceuticals, Inc.’s research and development focus. The report
|
more...
|
$500.00
|
|
ADVENTRX Pharmaceuticals, Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
ADVENTRX Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “ADVENTRX Pharmaceuticals - Product Pipeline Review - 2012” provides data on the ADVENTRX Pharmaceuticals’s research and development focus. The report includes information
|
more...
|
$500.00
|
|
Dainippon Sumitomo Pharma Co., Ltd. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Dainippon Sumitomo Pharma Co., Ltd. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Dainippon Sumitomo Pharma Co., Ltd. - Product Pipeline Review - 2012” provides data on the Dainippon Sumitomo Pharma Co., Ltd.’s
|
more...
|
$500.00
|
|
Eli Lilly and Company – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Eli Lilly and Company – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Eli Lilly and Company - Product Pipeline Review - 2012” provides data on the Eli Lilly and Company’s research and development
|
more...
|
$500.00
|
|
Emergent BioSolutions Inc. – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Emergent BioSolutions Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Emergent BioSolutions Inc. - Product Pipeline Review - 2012” provides data on the Emergent BioSolutions Inc.’s research and development focus. The report
|
more...
|
$500.00
|
|
Evotec Aktiengesellschaft – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Evotec Aktiengesellschaft – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Evotec Aktiengesellschaft - Product Pipeline Review - 2012” provides data on the Evotec Aktiengesellschaft’s research and development focus. The report includes information on
|
more...
|
$500.00
|
|
Mitsubishi Tanabe Pharma Corporation – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Mitsubishi Tanabe Pharma Corporation – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Mitsubishi Tanabe Pharma Corporation - Product Pipeline Review - 2012” provides data on the Mitsubishi Tanabe Pharma Corporation’s research and development
|
more...
|
$500.00
|
|
Neuren Pharmaceuticals Limited – Product Pipeline Review – 2012
5/15/2012 | published by: Global Markets Direct
Neuren Pharmaceuticals Limited – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Neuren Pharmaceuticals Limited - Product Pipeline Review - 2012” provides data on the Neuren Pharmaceuticals Limited’s research and development focus. The report
|
more...
|
$500.00
|
Related Markets
- Biotechnology
- General Biotechnology
- Research & Development
- Pharmaceuticals
- Pharmaceuticals Company Reports
- Research & Development
Research & Development Reports
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth
- Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation
- Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion
- Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules
